PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 84 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $18,000 | -91.8% | 59,457 | -88.4% | 0.00% | – |
| Q3 2016 | $220,000 | – | 512,873 | +51287200.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2016 | $14,000 | -85.6% | 35,501 | -58.2% | 0.00% | – |
| Q4 2015 | $97,000 | +73.2% | 85,024 | +54.5% | 0.00% | – |
| Q3 2015 | $56,000 | -95.6% | 55,044 | -94.3% | 0.00% | -100.0% |
| Q2 2015 | $1,260,000 | – | 962,731 | +370181.2% | 0.00% | – |
| Q1 2015 | $0 | – | 260 | +143.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 107 | -93.6% | 0.00% | – |
| Q3 2014 | $2,000 | -95.2% | 1,681 | -92.6% | 0.00% | – |
| Q2 2014 | $42,000 | -69.3% | 22,668 | -68.8% | 0.00% | – |
| Q1 2014 | $137,000 | +218.6% | 72,742 | +131.8% | 0.00% | – |
| Q4 2013 | $43,000 | -82.9% | 31,388 | -82.6% | 0.00% | – |
| Q3 2013 | $252,000 | – | 180,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
| First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
| Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
| FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
| Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
| Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
| REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
| PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |